ROS‐Activated Nanohydrogel Scaffolds with Multi‐Factors Controlled Release for Targeted Dual‐Lineage Repair of Osteochondral Defects
Advanced Science · 2025
DOI: 10.1002/advs.202412410 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Xiuhui Wang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Translational Medicine, Shanghai University, Shanghai, 200444, China. Hauptthemen laut MEDLINE: Tissue Scaffolds, Hydrogels, Reactive Oxygen Species. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Innovative Medical Device Application Project, Shanghai Municipal Hospital Development Center.
Abstract (Originalsprache)
Achieving self‐healing for osteochondral defects caused by trauma, aging, or disease remains a significant challenge in clinical practice. It is an effective therapeutic strategy to construct gradient‐biomimetic biomaterials that replicate the hierarchical structure and complex microenvironment of osteochondral tissues for dual‐lineage regeneration of both cartilage and subchondral bone. Herein, ROS‐activated nanohydrogels composite bilayer scaffolds with multi‐factors controlled release are rationally designed using the combination of 3D printing and gelatin placeholder methods. The resulting nanohydrogel scaffolds exhibit micro‐nano interconnected porous bilayer structure and soft‐hard complex mechanical strength for facilitating 3D culture of BMSCs in vitro. More importantly, multi‐stage continuous responses of anti‐inflammation, chondrogenesis and osteogenesis, are effectively induced via the sequential release of multi‐factors, including diclofenac sodium (DS), kartogenin (KGN) and bone morphogenetic protein 2 (BMP‐2), from ROS‐activated nanohydrogel scaffolds, thereby improved dual‐lineage regeneration of cartilage and subchondral bone tissue in the osteochondral defect model of SD rats. These findings suggest that ROS‐activated nanohydrogel scaffolds with such specific soft‐hard bilayer structure and sequential delivery of functional factors, provides a promising strategy in dual‐lineage regeneration of osteochondral defects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Translational Medicine, Shanghai University, Shanghai, 200444, China.
- Organoid Research Center, Shanghai University, Shanghai, 200444, China.
- National Center for Translational Medicine (Shanghai) SHU Branch, Shanghai University, Shanghai, 200444, China.
- Department of Orthopedics, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.
- Department of Clinical Laboratory, Shanghai Zhongye Hospital, Shanghai, 200941, China.
- Department of Orthopaedics, People's Liberation Army Joint Logistic Support Force 920th Hospital, Kunming, 650118, China.
ORCID-Profile: Jiacan Su
Förderung
- National Natural Science Foundation of China
- Shanghai Innovative Medical Device Application Project
- Shanghai Municipal Hospital Development Center
Zitieren
APA
Wang, X., Wu, S., Li, R., Yang, H., Sun, Y., Cao, Z., Chen, X., Hu, Y., Zhang, H., Geng, Z., Bai, L., Shi, Z., Xu, K., Tan, H., & Su, J. (2025). ROS‐Activated Nanohydrogel Scaffolds with Multi‐Factors Controlled Release for Targeted Dual‐Lineage Repair of Osteochondral Defects. Advanced Science. https://doi.org/10.1002/advs.202412410
Vancouver
Wang X, Wu S, Li R, Yang H, Sun Y, Cao Z, et al. ROS‐Activated Nanohydrogel Scaffolds with Multi‐Factors Controlled Release for Targeted Dual‐Lineage Repair of Osteochondral Defects. Advanced Science. 2025. doi:10.1002/advs.202412410
BibTeX
@article{Wang2025,
author = {Wang, Xiuhui and Wu, Shunli and Li, Ruiyang and Yang, Huijian and Sun, Yue and Cao, Zijie and Chen, Xiao and Hu, Yan and Zhang, Hao and Geng, Zhen and Bai, Long and Shi, Zhongmin and Xu, Ke and Tan, Hongbo and Su, Jiacan},
title = {ROS‐Activated Nanohydrogel Scaffolds with Multi‐Factors Controlled Release for Targeted Dual‐Lineage Repair of Osteochondral Defects},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202412410}
}
EUVIMED